Hyun Chul Chung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hyun Chul Chung has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Jae Hung Jung
Department of Precision Medicine and Urology, Yonsei University Wonju College of Medicine, Wonju, Korea
9 shared publications - Tae Wook Kang
Department of Urology, Yonsei University Wonju College of Medicine, Wonju, Korea
5 shared publications - Geehyun Song
Department of Urology, Center for Urologic Cancer, National Cancer Center, Goyang, Korea
3 shared publications - Hongzoo Park
Department of Urology, Kangwon National University School of Medicine, Chuncheon, Korea
3 shared publications - Jeong Hyun Kim
Department of Urology, Kangwon National University School of Medicine, Chuncheon, Korea
3 shared publications - Sang Baek Koh
Department of Preventive Medicine, Wonju College of Medicine, Yonsei University, Wonju, Republic of Korea
3 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in Investigative and Clinical Urology
- Vol. 67 (4) , 331-339
An artificial intelligence model integrating clinico-laboratory data and single nucleotide polymorphism-based genomic risk for prostate cancer diagnosis in Korean men
Jung JH, et al. Investig Clin Urol. 2026 ;67:e35. https://doi.org/10.4111/icu.20260002
- 1 January 2026
- Published by XMLink in Investigative and Clinical Urology
- Vol. 67 (4) , 331-339
Open AccessAn artificial intelligence model integrating clinico-laboratory data and single nucleotide polymorphism-based genomic risk for prostate cancer diagnosis in Korean men
Jung JH, et al. Investig Clin Urol. 2026 ;67:e35. https://doi.org/10.4111/icu.20260002
- Open Access
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44 (1) , 129-135
Development of a New Diagnostic Tool (LUTS/BPH Score) for Male Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
Jeh SU, et al. World J Mens Health. 2026 Jan;44(1):129-135. https://doi.org/10.5534/wjmh.240306
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44 (1) , 129-135
Open AccessDevelopment of a New Diagnostic Tool (LUTS/BPH Score) for Male Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia
Jeh SU, et al. World J Mens Health. 2026 Jan;44(1):129-135. https://doi.org/10.5534/wjmh.240306
- Open Access
- 31 August 2024
- Published by Korean Association of Urogenital Tract Infection and Inflammation in Urogenital Tract Infection
- Vol. 19 (2) , 44-47
Hyperbaric Oxygen Therapy for the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Case Report
Kwang Jin Kim, Yoonsuk Lee, Yong Sung Cha, Tae Wook Kang, Hyun Chul Chung, Hong Chung, Hyun Kim, Jae Hung Jung. Urogenit Tract Infect 2024;19:44-7. https://doi.org/10.14777/uti.2024.19.2.44
- 31 August 2024
- Published by Korean Association of Urogenital Tract Infection and Inflammation in Urogenital Tract Infection
- Vol. 19 (2) , 44-47
Open AccessHyperbaric Oxygen Therapy for the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Case Report
Kwang Jin Kim, Yoonsuk Lee, Yong Sung Cha, Tae Wook Kang, Hyun Chul Chung, Hong Chung, Hyun Kim, Jae Hung Jung. Urogenit Tract Infect 2024;19:44-7. https://doi.org/10.14777/uti.2024.19.2.44
- Open Access
- 31 December 2023
- Published by Korean Association of Urogenital Tract Infection and Inflammation in Urogenital Tract Infection
- Vol. 18 (3) , 101-106
Trends in Age-Specific Prevalence of Lower Urinary Tract Dysfunction: A Nationwide Population-Based Cohort Study
Young Hwan Kim, Se Hwa Hong, Tae Wook Kang, Hyun Chul Chung, Tae Hyoung Kim, Sae Chul Kim, Sang Baek Koh, Jae Hung Jung. Urogenit Tract Infect 2023;18:101-6. https://doi.org/10.14777/uti.2023.18.3.101
- 31 December 2023
- Published by Korean Association of Urogenital Tract Infection and Inflammation in Urogenital Tract Infection
- Vol. 18 (3) , 101-106
Open AccessTrends in Age-Specific Prevalence of Lower Urinary Tract Dysfunction: A Nationwide Population-Based Cohort Study
Young Hwan Kim, Se Hwa Hong, Tae Wook Kang, Hyun Chul Chung, Tae Hyoung Kim, Sae Chul Kim, Sang Baek Koh, Jae Hung Jung. Urogenit Tract Infect 2023;18:101-6. https://doi.org/10.14777/uti.2023.18.3.101
- Open Access
- 1 January 2022
- Published by XMLink in Investigative and Clinical Urology
- Vol. 63 (2) , 126-139
Tumor enucleation for the treatment of T1 renal tumors: A systematic review and meta-analysis
Chung HC, et al. Investig Clin Urol. 2022 Mar;63(2):126-139. https://doi.org/10.4111/icu.20210361
- 1 January 2022
- Published by XMLink in Investigative and Clinical Urology
- Vol. 63 (2) , 126-139
Open AccessTumor enucleation for the treatment of T1 renal tumors: A systematic review and meta-analysis
Chung HC, et al. Investig Clin Urol. 2022 Mar;63(2):126-139. https://doi.org/10.4111/icu.20210361
- Open Access
- 1 January 2021
- Published by SAGE Publications in Sage Open Medicine
- Vol. 9
Efficacy of 0.4 mg tamsulosin monotherapy in patients with moderate-to-severe lower urinary tract symptoms
To evaluate efficacy of 0.4 mg tamsulosin monotherapy in patients with benign prostatic hyperplasia with moderate-to-severe International Prostate Symptom Score. From May 2015 to May 2017, 102 patients were analyzed, retrospectively. The patients were classified into three groups according to the combination of medication (tamsulosin 0.4 mg vs tamsulosin 0.4 mg + solifenacin 5 mg vs tamsulosin 0.4 mg + mirabegron 50 mg). Baseline characteristics (e.g. age, body weight, height, and underlying medical disease) were collected. International Prostate Symptom Score, prostate specific antigen, prostate volume, peak urinary flow rate (Qmax), voided volume, and post-voided volume before after treatment were evaluated. We classified and analyzed the patients into three groups depending on the medication. And there were no significant differences between all parameters among the groups. Voided volume at 3 months after treatment in each group was 170.54 ± 125.83, 121.55 ± 46.19, and 274.63 ± 132.30 (p = 0.019). Differences of voiding symptom score and difference of post-voided volume among the groups before after treatment was 5.00 ± 5.42, 1.92 ± 3.92, and 0.11 ± 5.11 and 8.37 ± 34.32, 0.78 ± 14.86, −33.63 ± 28.58 (p = 0.037, p = 0.007). We think tamsulosin monotherapy will be feasible as a first-line therapy for the patients with benign prostatic hyperplasia who has struggled with moderate-to-severe lower urinary tract symptoms.
- 1 January 2021
- Published by SAGE Publications in Sage Open Medicine
- Vol. 9
Open AccessEfficacy of 0.4 mg tamsulosin monotherapy in patients with moderate-to-severe lower urinary tract symptoms
To evaluate efficacy of 0.4 mg tamsulosin monotherapy in patients with benign prostatic hyperplasia with moderate-to-severe International Prostate Symptom Score. From May 2015 to May 2017, 102 patients were analyzed, retrospectively. The patients were classified into three groups according to the combination of medication (tamsulosin 0.4 mg vs tamsulosin 0.4 mg + solifenacin 5 mg vs tamsulosin 0.4 mg + mirabegron 50 mg). Baseline characteristics (e.g. age, body weight, height, and underlying medical disease) were collected. International Prostate Symptom Score, prostate specific antigen, prostate volume, peak urinary flow rate (Qmax), voided volume, and post-voided volume before after treatment were evaluated. We classified and analyzed the patients into three groups depending on the medication. And there were no significant differences between all parameters among the groups. Voided volume at 3 months after treatment in each group was 170.54 ± 125.83, 121.55 ± 46.19, and 274.63 ± 132.30 (p = 0.019). Differences of voiding symptom score and difference of post-voided volume among the groups before after treatment was 5.00 ± 5.42, 1.92 ± 3.92, and 0.11 ± 5.11 and 8.37 ± 34.32, 0.78 ± 14.86, −33.63 ± 28.58 (p = 0.037, p = 0.007). We think tamsulosin monotherapy will be feasible as a first-line therapy for the patients with benign prostatic hyperplasia who has struggled with moderate-to-severe lower urinary tract symptoms.
- Open Access
- 1 January 2021
- Published by Korean Society for Sexual Medicine and Andrology in The World Journal of Men's Health
- Vol. 39 (1) , 158-167
Trends in End-of-Life Resource Utilization and Costs among Prostate Cancer Patients from 2006 to 2015: A Nationwide Population-Based Study
Ha YS, et al. World J Mens Health. 2021 Jan;39(1):158-167. https://doi.org/10.5534/wjmh.200113
- 1 January 2021
- Published by Korean Society for Sexual Medicine and Andrology in The World Journal of Men's Health
- Vol. 39 (1) , 158-167
Open AccessTrends in End-of-Life Resource Utilization and Costs among Prostate Cancer Patients from 2006 to 2015: A Nationwide Population-Based Study
Ha YS, et al. World J Mens Health. 2021 Jan;39(1):158-167. https://doi.org/10.5534/wjmh.200113
- Open Access
- 1 January 2020
- Published by The Korean Urological Association in Investigative and Clinical Urology
- Vol. 61 (1) , 42-50
Preoperative prostate health index and %p2PSA as the significant biomarkers of postoperative pathological outcomes of prostate cancer in Korean males: A prospective multi-institutional study
To evaluate the clinical utility of percentage of serum prostate-specific antigen (proPSA) to free PSA (%p2PSA) and the prostate health index (PHI) for predicting aggressive pathological outcomes of radical prostatectomy (RP) in Korean males. This prospective observational multicenter study included 160 Korean males who consecutively underwent RP. The predictive utility of preoperative %p2PSA and PHI for predicting the following pathological outcomes of RP including pT3 disease, pathologic Gleason sum ≥7, and Gleason sum upgrading was investigated using multivariate and decision-curve analyses. The PHI and %p2PSA levels were significantly higher in patients with pT3 disease, pathologic Gleason sum ≥7, and Gleason sum upgrading. On univariate analysis, PHI was an accurate predictor of pT3 disease, pathologic Gleason sum ≥7, and Gleason sum upgrading. Multivariate and decision curve analyses revealed that inclusion of PHI to a base multivariate model including total PSA, percentage free PSA, PSA density, percentage of positive biopsy core, biopsy Gleason sum, and clinical stage factors significantly increased its predictive accuracy; %p2PSA showed a similar result. However, PHI was a more valuable predictor of pathological outcomes of RP. This study revealed PHI and %p2PSA as preoperative biomarkers of pathological outcomes in Korean males who underwent RP for prostate cancer.
- 1 January 2020
- Published by The Korean Urological Association in Investigative and Clinical Urology
- Vol. 61 (1) , 42-50
Open AccessPreoperative prostate health index and %p2PSA as the significant biomarkers of postoperative pathological outcomes of prostate cancer in Korean males: A prospective multi-institutional study
To evaluate the clinical utility of percentage of serum prostate-specific antigen (proPSA) to free PSA (%p2PSA) and the prostate health index (PHI) for predicting aggressive pathological outcomes of radical prostatectomy (RP) in Korean males. This prospective observational multicenter study included 160 Korean males who consecutively underwent RP. The predictive utility of preoperative %p2PSA and PHI for predicting the following pathological outcomes of RP including pT3 disease, pathologic Gleason sum ≥7, and Gleason sum upgrading was investigated using multivariate and decision-curve analyses. The PHI and %p2PSA levels were significantly higher in patients with pT3 disease, pathologic Gleason sum ≥7, and Gleason sum upgrading. On univariate analysis, PHI was an accurate predictor of pT3 disease, pathologic Gleason sum ≥7, and Gleason sum upgrading. Multivariate and decision curve analyses revealed that inclusion of PHI to a base multivariate model including total PSA, percentage free PSA, PSA density, percentage of positive biopsy core, biopsy Gleason sum, and clinical stage factors significantly increased its predictive accuracy; %p2PSA showed a similar result. However, PHI was a more valuable predictor of pathological outcomes of RP. This study revealed PHI and %p2PSA as preoperative biomarkers of pathological outcomes in Korean males who underwent RP for prostate cancer.
- Open Access
- 30 April 2019
- Published by Korean Urological Oncology Society in The Korean Journal of Urological Oncology
- Vol. 17 (1) , 66-69
Primary Leiomyosarcoma in Bladder
- 30 April 2019
- Published by Korean Urological Oncology Society in The Korean Journal of Urological Oncology
- Vol. 17 (1) , 66-69
Open AccessPrimary Leiomyosarcoma in Bladder
- 21 August 2018
- Published by Wiley in Andrologia
- Vol. 50 (10) , e13125
Association between the symptoms of benign prostatic hyperplasia and social disparities: Does social capital promote prostate health?
This cross‐sectional study investigated the relationships between socioeconomic factors and social capital and benign prostatic hyperplasia symptoms. The participants were 100,000 adult men who participated in the Korea Community Health Survey. The surveyors used the International Prostate Symptom Score. As regards occupation, the prevalence of benign prostatic hyperplasia was higher in men with blue‐collar occupations or those who were unemployed than in those with white‐collar jobs. In terms of marital status, the prevalence of benign prostatic hyperplasia was 1.319 times higher among divorced men than married men. As regards social capital, the prevalence of benign prostatic hyperplasia in men with positive attitudes towards one's community scores that reflected good, poor and very poor community scores was 1.228, 1.246 and 1.447 times higher than that of men who had very good scores respectively. The groups with good, poor, and very poor community participation scores had 1.115, 1.202 and 1.364 times higher prevalence of benign prostatic hyperplasia than the group with very good scores. Social disparities and social capital of a community were associated with the prevalence of benign prostatic hyperplasia. Thus, the use of social capital in the community setting will be effective in the management of the condition.
- 21 August 2018
- Published by Wiley in Andrologia
- Vol. 50 (10) , e13125
Association between the symptoms of benign prostatic hyperplasia and social disparities: Does social capital promote prostate health?
This cross‐sectional study investigated the relationships between socioeconomic factors and social capital and benign prostatic hyperplasia symptoms. The participants were 100,000 adult men who participated in the Korea Community Health Survey. The surveyors used the International Prostate Symptom Score. As regards occupation, the prevalence of benign prostatic hyperplasia was higher in men with blue‐collar occupations or those who were unemployed than in those with white‐collar jobs. In terms of marital status, the prevalence of benign prostatic hyperplasia was 1.319 times higher among divorced men than married men. As regards social capital, the prevalence of benign prostatic hyperplasia in men with positive attitudes towards one's community scores that reflected good, poor and very poor community scores was 1.228, 1.246 and 1.447 times higher than that of men who had very good scores respectively. The groups with good, poor, and very poor community participation scores had 1.115, 1.202 and 1.364 times higher prevalence of benign prostatic hyperplasia than the group with very good scores. Social disparities and social capital of a community were associated with the prevalence of benign prostatic hyperplasia. Thus, the use of social capital in the community setting will be effective in the management of the condition.